Calvert Formula, Ghazali

GFR, Ghazali

The Calvert (Ghazali) formula calculates carboplatin dose by targeting a desired AUC using measured or estimated GFR to individualize exposure.

kglbs
mg/dlmcmol/L
yrs
sq.m
mg/ml*min

Indications for Use

Dose according to renal function to individualize carboplatin exposure (AUC‑targeted therapy) in solid tumors; used when accurate GFR assessment is essential to avoid over‑ or under‑dosing. Provides consistent AUC prediction and safer myelosuppression risk control 1 [Level I evidence].

Used to estimate carboplatin clearance from standard patient variables when direct GFR measurement is unavailable, supporting individualized dosing across diverse body sizes 2 [Level II evidence].

Insights & Cautions

Start by using measured or cystatin‑C–creatinine eGFR when possible to reduce misdosing; eGFRcr alone overdoses 10–20% of patients 1 [Level II evidence].

  • Enzymatic creatinine assays can overestimate clearance—adding 0.2 mg/dL prevents thrombocytopenia 2 [Level II evidence].
  • Non‑renal clearance may be <25 mL/min in some populations, risking overdose at low GFR 3 [Level II evidence].
  • Avoid formula use in unstable renal function; prefer measured GFR.